TRI Grant Schemes

TRI offers two grant schemes to support translational research projects based at TRI: Spore and Drive.

Spore Grants

These grants are awarded to support multidisciplinary teams of scientists and clinicians from a combination of academic, commercial and clinical backgrounds to test innovative ideas. 

The scheme provides funding of up to $90,000 per grant for 12 months. 

The 2019 grant round is closed. Successful recipients to be announced.

Find out more about how to apply.

TRI has awarded eight Spore Grants since 2015 (see 2016 winners and 2018 winners). 

Drive Grants

The Drive Grant scheme aims to accelerate translation of innovations into the clinic, bringing together multidisciplinary teams of scientists, clinicians and commercial partners to address an unmet clinical need. 

This scheme supports research projects that are beyond proof-of-concept stage, address an important clinical question, and have a defined translational outcome. Areas of interest can include, but are not limited to, research addressing new therapeutics, diagnostics, medical devices, digital health, new clinical intervention programs and repurposing of new drugs. 

The scheme provides funding of up to $5000,000 per grant over three years. 

The 2019 grant round is closed.

Find out more about how to apply.